Grants & Programs

Development of Surrogate Endpoints for Cancer Immunotherapy Trials

October 05, 2014
07:00 AM
Grand Hyatt New York Hotel at Grand Central, New York, NY
View Map
Add To Calendar:
Outlook Google iCal
This year, in conjunction with the CRI Symposium, we will be hosting a special Cancer Immunotherapy Consortium (CIC) satellite meeting on Sunday, October 5, 2014 entitled Development of Surrogate Endpoints for Cancer Immunotherapy Trials. The meeting will consist of a full day of presentations and panel discussions addressing the key rationale, challenges, and solutions surrounding the development of surrogate endpoints for cancer immunotherapy. This meeting will represent the culmination of a CIC-led community-wide effort that brings together the major stakeholders in the field, including experts from industry, academia, and regulatory bodies as well as patients. The output of the meeting will be a consensus-driven roadmap for the efficient regulatory approval of future immunotherapies.

Please note: Separate registration is required for the CRI Symposium and CIC Satellite Meeting. Attendance to the CIC Meeting is complimentary for 2014 CRI Symposium registrants. To receive complimentary registration, on the registration page you will be prompted to enter the 8-digit Registration ID you received in your symposium confirmation email. Click here to register for the 2014 CRI Symposium (October 6-8).